Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Abate-Daga

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Molecular Therapy Oncolytics|May 28, 2016
CAR models: next-generation CAR modifications for enhanced T-cell functionDaniel Abate-Daga, Marco L Davila
Journal of the National Cancer Institute|May 15, 2018
Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus OncolysisPeter A Forsyth, Daniel Abate-Daga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Oncolytic Virotherapy for Malignant GliomasPeter A Forsyth, Daniel Abate-Daga
Frontiers in Immunology|May 3, 2024
Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performanceMarta Barisa, Daniel Abate-Daga, Jonathan Fisher
Oncoimmunology|August 2, 2014
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapiesDaniel Abate-Daga, Steven A Rosenberg, Richard A Morgan
Pharmacological Research|December 6, 2017
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Maria C Ramello, Eric B Haura, Daniel Abate-Daga
Biochimica Et Biophysica Acta|July 6, 2010
Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cellsDaniel Abate-Daga, Laura Garcia-Rodríguez, Lauro Sumoy, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges aheadKedar Kirtane, Hany Elmariah, Christine H Chung, et al.
Cancer Journal (Sudbury, Mass.)|July 26, 2022
γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial TumorsXiomar Bustos, Sebastian Snedal, Leticia Tordesillas, et al.
Nature Communications|May 22, 2026
Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapiesJonathan Fisher, Yin Wu, Daniel Abate-Daga, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Molecular Therapy Oncolytics|May 28, 2016
CAR models: next-generation CAR modifications for enhanced T-cell functionDaniel Abate-Daga, Marco L Davila
Journal of the National Cancer Institute|May 15, 2018
Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus OncolysisPeter A Forsyth, Daniel Abate-Daga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Oncolytic Virotherapy for Malignant GliomasPeter A Forsyth, Daniel Abate-Daga
Frontiers in Immunology|May 3, 2024
Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performanceMarta Barisa, Daniel Abate-Daga, Jonathan Fisher
Oncoimmunology|August 2, 2014
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapiesDaniel Abate-Daga, Steven A Rosenberg, Richard A Morgan
Pharmacological Research|December 6, 2017
CAR-T cells and combination therapies: What's next in the immunotherapy revolution?Maria C Ramello, Eric B Haura, Daniel Abate-Daga
Biochimica Et Biophysica Acta|July 6, 2010
Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cellsDaniel Abate-Daga, Laura Garcia-Rodríguez, Lauro Sumoy, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges aheadKedar Kirtane, Hany Elmariah, Christine H Chung, et al.
Cancer Journal (Sudbury, Mass.)|July 26, 2022
γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial TumorsXiomar Bustos, Sebastian Snedal, Leticia Tordesillas, et al.
Nature Communications|May 22, 2026
Harnessing the potential of γδ T cells through engineering and combination treatment for cancer therapiesJonathan Fisher, Yin Wu, Daniel Abate-Daga, et al.
Pageof 5